Please use this identifier to cite or link to this item:
Title: Chemokines as therapeutic targets in systematic inflammatory response syndrome
Authors: HE MIN
Keywords: chemokines, sepsis, acute pancreatitis
Issue Date: 16-Dec-2008
Citation: HE MIN (2008-12-16). Chemokines as therapeutic targets in systematic inflammatory response syndrome. ScholarBank@NUS Repository.
Abstract: Exaggerated systemic inflammatory response syndrome may lead to multiple organ dysfunction, organ failure and eventually death. Chemokines, a large family of small chemotactic cytokines, are critical inflammatory mediators in the development of both acute pancreatitis and sepsis. The present study has shown that blockage of CCR1 by a small molecule CCR1 antagonist has protective effect against acute lung injury in animal models of acute pancreatitis and sepsis. Depletion of mast cells by compound 48/80 has also attenuated acute pancreatitis-associated lung injury and sepsis-associated lung injury by attenuating the levels of chemokines. Treatment with an exogenous CX3C chemokine FTK has shown pro-inflammatory effect in acute pancreatitis-associated lung injury and anti-inflammatory effect against sepsis-associated lung injury. These promising findings validate that manipulating chemokine system may have protective effect in systemic inflammatory response syndrome.
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
HeM.pdf2.84 MBAdobe PDF



Page view(s)

checked on Dec 16, 2018


checked on Dec 16, 2018

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.